None listed
Conditions
Brief summary
To study whether oncological physiotherapy treatment with manual intracavitary lymphatic drainage (MiLD) in patients with vaginal narrowing or stenosis due to the oncological treatments received is more effective than conventional treatment. The experimental group will receive intracavitary manual lymphatic drainage (DLMi), applied by a specialized physiotherapist in 8 weekly sessions lasting 20 minutes. This technique involves slow, targeted internal maneuvers with the fingers to stimulate lymphatic drainage in the vaginal and external genital areas. The control group will use vaginal dilators at home for 8 weeks, inserting progressively larger dilators during weekly 20-minute sessions, with indirect professional guidance.
Interventions
Experimental group: Intracavitary Manual Lymphatic Drainage (IMLD) treatment. The intervention in the experimental group will be carried out by a specialised physiotherapist. The treatment will consist of IMLD, one session per week lasting 20 minutes, for 8 weeks. The patient will be placed in supine decubitus with hip flexion of 90o and knee flexion greater than 90o in both lower limbs. If the protocol is performed on a gynaecological examination couch, the patient is placed in the lithotomy position, the usual position for gynaecological examination, in which the patient is in the supine decubitus position, with 90o flexion of both coxofemoral joints and the knees, maintaining abduction of both lower limbs, with the possibility of support on leg supports or a heel stirrup, which allows the lower limbs to relax. The physiotherapist is positioned on one side of the couch or in front of the patient in the case of the gynaecological examination couch. The physiotherapist places his hand in neutral wrist flexion-extension and introduces his index finger and middle finger into the vaginal cavity, after lubrication with a gel, placing his forearm in neutral pronation-supination position. Once the fingers have been inserted approximately 5 centimetres into the vaginal cavity, a slow pronation movement of the forearm is performed. With this prior positioning of the patient and the physiotherapist, we begin the technique, the time for manual intracavitary and external genital lymphatic drainage will be 20 minutes. Technique: The IMLD technique is an adaptation of the resorption manoeuvre described by Leduc(138) to the anatomical area of application. The technique is performed with the index and middle finger, starting the manoeuvre from the proximal phalanx and pushing towards the distal phalanx, in the form of a blotting tampon. The approach areas are the posterior wall of the vagina, and both lateral walls, repeating the manoeuvre on each wall several times. The purpose of this manoeuvre is to reduce oedema and vulvar congestion, draining the lymphatic load in the direction of the inguinal and external iliac nodes. Once the intracavitary treatment has been completed, we will perform a Manual Lymphatic Drainage (MLD) on the external genitalia, supra pubic and inguinal areas, carrying out the following manoeuvres: - Vodder's fixed circles - Classic Leduc resorption To assess adherence to the intervention, several strategies will be employed. Attendance will be recorded at each treatment session, and participants will be asked to sign a session log. In addition, medical records will be reviewed to verify relevant clinical history and continuity of care. Personalized follow-up will be conducted, either in person or by phone, to reinforce adherence and identify any potential barriers. Any incidents, missed sessions, or changes in the treatment plan will be documented by the treating physiotherapist. The technique used will be Intracavitary IMLD, specifically applied via the vaginal route. The maneuver will consist of gentle, rhythmic, and slow manual mobilizations within the vaginal canal, following the physiological direction of lymphatic flow toward the inguinal lymph nodes. The intervention will be performed exclusively by physiotherapists specialized in pelvic floor rehabilitation and lymphatic drainage. The specific application of the technique, including intensity, duration, and frequency, will be tailored to each patient based on clinical evaluation, the degree of vaginal stenosis, and always under medical indication and consent, in coordination with the oncology and gynecology teams.
Sponsors
Study design
Eligibility
Inclusion criteria
Inclusion criteria - Women aged between 18 and 65 years. - Breast cancer patients diagnosed with treatment-related vaginal stenosis. - Patients who have received QT/RT/BT treatment in the past. - Patients with and without hormone suppressor treatment. - Signed informed consent.
Exclusion criteria
Exclusion criteria - Patients who do not accept intracavitary treatment. - Patients with abdominopelvic surgical treatment prior to the oncological process. - Patients diagnosed with dyspareunia prior to cancer. - Patients with vaginal narrowing prior to cancer. - Patients with menopause at the time of cancer diagnosis. - Pregnant women. - Patients with decompensated heart disease. - Untreated malignant cancer - Acute infection - Acute (uncontrolled) allergy. - Medical diagnosis of endometriosis.